These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Development and evaluation of a generic physiologically based pharmacokinetic model for children. Edginton AN; Schmitt W; Willmann S Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214 [TBL] [Abstract][Full Text] [Related]
26. The clinical pharmacokinetics of levofloxacin. Fish DN; Chow AT Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [TBL] [Abstract][Full Text] [Related]
27. Development of mechanisms for drug excretion. Hook JB; Hewitt WR Am J Med; 1977 Apr; 62(4):497-506. PubMed ID: 851120 [TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Lau AH; Lam NP; Piscitelli SC; Wilkes L; Danziger LH Clin Pharmacokinet; 1992 Nov; 23(5):328-64. PubMed ID: 1478003 [TBL] [Abstract][Full Text] [Related]
29. Clinical pharmacokinetics in patients with burns. Jaehde U; Sörgel F Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895 [TBL] [Abstract][Full Text] [Related]
30. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use. Kearns GL; Young RA Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281 [TBL] [Abstract][Full Text] [Related]
31. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Strolin Benedetti M; Whomsley R; Baltes EL Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):447-71. PubMed ID: 16863455 [TBL] [Abstract][Full Text] [Related]
32. Linezolid pharmacokinetics in pediatric patients: an overview. Jungbluth GL; Welshman IR; Hopkins NK Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of carbamazepine in the neonate and in the child. Rey E; d'Athis P; de Lauture D; Dulac O; Aicardi J; Olive G Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):90-6. PubMed ID: 422308 [TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis. Prandota J Drugs; 1988 May; 35(5):542-78. PubMed ID: 3293970 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human. Timchalk C; Nolan RJ Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410 [TBL] [Abstract][Full Text] [Related]
37. Predictability of the effects of race or ethnicity on pharmacokinetics of drugs. Johnson JA Int J Clin Pharmacol Ther; 2000 Feb; 38(2):53-60. PubMed ID: 10706191 [TBL] [Abstract][Full Text] [Related]
38. Effects of surgery on the pharmacokinetic parameters of drugs. Kennedy JM; Riji AM Clin Pharmacokinet; 1998 Oct; 35(4):293-312. PubMed ID: 9812179 [TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics of the antituberculosis drugs. Holdiness MR Clin Pharmacokinet; 1984; 9(6):511-44. PubMed ID: 6391781 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and prescribing in the elderly. Swift CG J Antimicrob Chemother; 1994 Aug; 34 Suppl A():25-32. PubMed ID: 7844071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]